Am. J. Respir. Crit. Care Med., Volume 164, Number 4, August 2001, 657-660

Percutaneous Pulmonary Artery and Vein Stenting
A Novel Treatment for Mediastinal Fibrosis

THOMAS P. DOYLE, JAMES E. LOYD, and IVAN M. ROBBINS

Division of Pediatric Cardiology and Center for Lung Research, Department of Medicine, Vanderbilt University School of Medicine, Nashville, Tennessee

Mediastinal fibrosis is a rare consequence of infection with the fungus Histoplasma capsulatum that can lead to occlusion of large pulmonary arteries and veins and mainstem bronchi. Medical and surgical treatments for this disorder have been ineffective. We describe successful treatment for central pulmonary arterial and venous obstruction due to mediastinal fibrosis in four patients using percutaneously placed intravascular stents. Patients were severely limited, World Health Organization functional class III or IV. At the time of right and left heart catheterization, stents were placed in pulmonary arteries (n = 1), veins (n = 2), or both (n = 1) to relieve vascular obstruction resulting from mediastinal fibrosis. Immediate hemodynamic and clinical improvement was observed in all patients. Three of the four patients have had sustained improvement in exercise tolerance, from 3.5 mo to 4.5 yr after stent placement. The only complication was a self-limited pulmonary hemorrhage in one patient. Our initial experience suggests that percutaneous stent placement to relieve central pulmonary arterial or venous obstruction due to mediastinal fibrosis is an effective new treatment modality.

This article has been cited by other articles:

				F. Yangui, J-P. Battesti, D. Valeyre, A. B. Kheder, and P-Y. Brillet Fibrosing mediastinitis as a rare mechanism of pulmonary oedema in sarcoidosis Eur. Respir. J., February 1, 2010; 35(2): 455 - 456. [Full Text] [PDF]

				Z. T. Hammoud, A. S. Rose, C. A. Hage, K. S. Knox, K. Rieger, and K. A. Kesler Surgical Management of Pulmonary and Mediastinal Sequelae of Histoplasmosis: A Challenging Spectrum Ann. Thorac. Surg., August 1, 2009; 88(2): 399 - 403. [Abstract] [Full Text] [PDF]

				M. L. Brown, A. R. Cedeno, E. S. Edell, D. J. Hagler, and H. V. Schaff Operative strategies for pulmonary artery occlusion secondary to mediastinal fibrosis. Ann. Thorac. Surg., July 1, 2009; 88(1): 233 - 237. [Abstract] [Full Text] [PDF]

				A. S. Rose, K. S. Knox, and C. A. Hage A 24-Year-Old Man With Mediastinal Mass, Dyspnea, and a Pleural Effusion Chest, July 1, 2008; 134(1): 200 - 203. [Full Text] [PDF]

				C. A. Kauffman Histoplasmosis: a Clinical and Laboratory Update Clin. Microbiol. Rev., January 1, 2007; 20(1): 115 - 132. [Abstract] [Full Text] [PDF]

				A. M. Qureshi, L. R. Prieto, L. A. Latson, G. K. Lane, C. I. Mesia, P. Radvansky, R. D. White, N. F. Marrouche, E. B. Saad, D. L. Bash, et al. Transcatheter Angioplasty for Acquired Pulmonary Vein Stenosis After Radiofrequency Ablation Circulation, September 16, 2003; 108(11): 1336 - 1342. [Abstract] [Full Text] [PDF]

				D. R. Thickett, L. Armstrong, and A. B. Millar A Role for Vascular Endothelial Growth Factor in Acute and Resolving Lung Injury Am. J. Respir. Crit. Care Med., November 15, 2002; 166(10): 1332 - 1337. [Abstract] [Full Text] [PDF]

				M. J. TOBIN Chronic Obstructive Pulmonary Disease, Pollution, Pulmonary Vascular Disease, Transplantation, Pleural Disease, and Lung Cancer in AJRCCM 2001 Am. J. Respir. Crit. Care Med., March 1, 2002; 165(5): 642 - 662. [Full Text] [PDF]